Pineridge Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$12.8K Buy
69
+8
+13% +$1.37K ﹤0.01% 186
2025
Q2
$9.3K Buy
61
+10
+20% +$1.54K ﹤0.01% 228
2025
Q1
$8.4K Sell
51
-729
-93% -$114K ﹤0.01% 251
2024
Q4
$113K Buy
780
+253
+48% +$39.2K 0.04% 90
2024
Q3
$85.4K Sell
527
-71
-12% -$11.3K 0.03% 102
2024
Q2
$87.4K Sell
598
-66
-10% -$9.82K 0.03% 107
2024
Q1
$105K Sell
664
-565
-46% -$89.9K 0.04% 85
2023
Q4
$193K Buy
+1,229
New +$188K 0.06% 71

Other funds holding JNJ

Pineridge Advisors's JNJ Position: Q3 2025 in Review

Pineridge Advisors increased its Johnson & Johnson (JNJ) stake by 13% in Q3 2025, buying an estimated $1.37K and bringing the position to 69 shares worth $12.8K. The position accounts for ﹤0.01% of the portfolio, ranked #186.

Pineridge Advisors first reported a position in JNJ in Q4 2023 and has held it in 8 quarters since. The position peaked at $193K in Q4 2023. 4,187 funds tracked by Wall St. Rank hold JNJ as of Q3 2025.

  • Pineridge Advisors held 69 shares of Johnson & Johnson worth $12.8K as of Q3 2025.
  • Pineridge Advisors bought 8 Johnson & Johnson shares in Q3 2025, an estimated $1.37K.
  • Johnson & Johnson made up ﹤0.01% of Pineridge Advisors's portfolio in Q3 2025, its #186 holding.
  • Pineridge Advisors first reported a position in Johnson & Johnson in Q4 2023 and has held it in 8 quarters since.
  • Pineridge Advisors's Johnson & Johnson position peaked at $193K in Q4 2023.
  • 4,187 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2025.

Based on Pineridge Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.